Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing ...

Koreas biotech firms strive for growth amid investment challenges at JP Morgan event K-Bio executives highlight new strategies to adapt in a challenging investment landscape at a major healthcare gath ...

Belle da Costa Greene, who was JP Morgan’s librarian, became a lively fixture at Gilded Age mansions, country retreats, ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.Cho0xxI9.js ...

K-Bio leaders pursue U.S. factories and conferences during Lunar New Year K-Bio executives opt for international business ...

As the J.P. Morgan Healthcare Conference started in San Francisco on Monday, AbbVie linked up with Simcere with a $1 billion ...

The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...

JPMorgan Chase & Co. boosted its holdings in shares of Belite Bio, Inc (NASDAQ:BLTE – Free Report) by 7,122.7% in the 3rd ...

Local biotech leaders are heading to San Francisco for the 2025 J.P. Morgan Healthcare Conference, one of the industry's biggest annual events. Hotels have been booked, the meetings scheduled and ...

SEOUL, South Korea, Jan. 17, 2025 /PRNewswire/ -- LOTTE BIOLOGICS (CEO James Park) announced on January 16 that it had ...

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced its ...